Mental Health, Misdiagnosis, Marijuana, Medical Malpractice: Meet Your New Drug Dealer, Dr. Stupid, and The Clinical Assessment at Your MAT

 Author’s Declaration of Fair Comment: When you inject academic data into the public domain to influence national public health policy, you do not get to hide behind a clipboard when the data is forensically challenged. The following is a direct, First Amendment-protected critique of the study "Psychiatric comorbidities in substance use disorders: sex-based differences in a national real-world clinical sample" by Butelman et al., published in the American Journal of Psychiatry (2026), and subsequently promoted by Vivien Ciftci on The Mental Elf. As a published author, forensic expert witness across more than 4,000 legal cases, and a PhD-level addiction clinician with 20 years of practice, I possess the absolute right to mock, dismantle, and publicly debate deeply flawed academic methodology. If the authors dislike having their conclusions forensically eviscerated, someone else is welcome to debate my public domain entrance into this argument. No feelings here. Just facts.

Section 1: The Diagnostic Shell Game and the Academic Vacuum

Two people walk into a psychiatric clinic. One is male, one is female. Both are actively drinking, shooting synthetic opioids, or smoking high-potency weed from dawn until dark.

The academic researchers—in this case, Butelman et al., clutching their dataset of 58,000 state-funded patients and looking through the lens of the American Journal of Psychiatry—gaze at them with profound intellectual wonder and ask: “Why do these two individuals present with such starkly different psychiatric comorbidities? Could it be biological? Societal? Hormonal?”

Allow a clinician who actually spent decades in the trenches to answer the question without charging taxpayers a dime: They don’t have mysterious psychiatric comorbidities. They have a central nervous system drowning in chemicals.

If you pour half a gallon of distilled ethanol into your engine every morning, you don’t need an engine whisperer to diagnose why the exhaust is sputtering. If you put a heavy central nervous system depressant into a person for 20 years, they are going to present as profoundly depressed. If you pump 25 milligrams of Delta-9 THC into a person, their oars are not going to be in the water. If someone has spent a decade abusing opioids, they are going to walk through the clinic doors emotionally and psychologically evaporated, completely drained of executive function.

Yet modern state-run clinics, operating under the gospel of the DSM and subsidized by bottomless Medicaid streams, perform a magnificent piece of diagnostic sleight-of-hand. They look at someone going through active toxicity or severe chemical withdrawal and decide to throw a psychological hand grenade into the mix. They tell the patient, "Since you drank and used drugs to numb out, we are going to help you do that with a brand-new pill. Oh, and we'll increase the dose in two weeks because, naturally, you're not going to feel very good while your brain chemistry burns to the ground."

It is the old English medical adage brought to horrific modern life: The operation was a success, but the patient died.

Translated into plain English: “Congratulations! Meet your new drug dealer, it’s called MAT (Medication-Assisted Treatment). By the way, your doctor will be turning you into a vegetable today, enthusiastically supported by the nurse practitioner and the LPN. And if you have any trouble getting what you need from our clinic because we want to preserve our clean billing codes, don't worry—we’ll refer you to a Telemed doctor who can ship you anything right on up to Ketamine. Because if it can tank a 2,000-pound horse, it should do wonders for a 175-pound addict.”

The single biggest flaw in the Butelman argument—and the entire modern addiction apparatus they are studying—is the sheer, breathtaking incompetence of the clinical assessment. They treat patients in a complete vacuum, ignoring the origin story and discarding every single genetic and psychiatric clue.

The current chemical dependency assessment utilized across the Medicaid pipeline is little more than a 17-question joke. It only asks about the last three years, tracking minor usage just enough to generate a billing code.

Section 2: The Assessment Vacuum and the Death of the AMA Standard

Before we dive further into the comedic tragedy of this study’s “findings,” we need to establish exactly how far the clinical standard has fallen. If you want to understand how a study published in the American Journal of Psychiatry can claim with a straight face that drug addicts are suffering from sudden, sex-based outbreaks of schizophrenia and bipolar disorder, you have to look at what they threw in the garbage to get here.

For 50 to 60 years, the gold standard for treating addiction was established by the American Medical Association (AMA). It relied on a rigorous, differential diagnosis of chemical dependency. When you walked into a clinic during the Golden Age of Recovery, you didn't get a 17-question checklist that only cared about the last three years of your life so a billing clerk could code your chart. You sat down for a grueling, comprehensive, two-and-a-half-hour forensic assessment.

We mapped everything. We wanted to know what you took, how much you took, and exactly when you started taking it. If you were sitting in my chair, I already knew you weren't an amateur. People don't end up in an addiction therapist's office on a winning streak. If you are sitting in that chair, you are in so much pain that you have finally decided you are sick and tired of being sick and tired. You are ready to hear the unvarnished truth about your disease, and you are ready to learn how to recover. We traced genetic predispositions back two full generations—direct lines through Mom, Dad, Grandma, and Grandpa—looking for the presence of alcoholism, drug addiction, hypoglycemia, diabetes, and actual organic mental illness.

Here is the absolute, unbendable clinical rule that modern psychiatry has conveniently "forgotten" to preserve their $1.5 trillion billing cycle: Every single sign and symptom of drug use and chemical withdrawal mimics mental illness 100%.

If a patient did not have a documented, severe psychiatric episode—like schizophrenia, manic depression, or a psychotic break—two, three, five, or ten years before their very first use of an intoxicating substance, and there is no two-generation genetic predisposition, there is almost certainly no organic mental illness. You cannot accurately diagnose the presence of a primary psychiatric disorder until the individual has achieved a minimum of six months of continuous, long-term, abstinence-based recovery.

But the American Psychiatric Association (APA) and the Medicaid billing machinery hijacked that standard. The current system has had one job for the last 26 years: keep you addicted, keep you sedated, and keep you walking through that revolving door of failure. By eliminating the AMA's deep-dive assessment, the APA created a clinical vacuum. They purposely ignore whether a patient was getting black-out drunk at age 14 before they ever felt "depressed." They ignore it because finding out that the drugs caused the psychiatric symptoms ruins the justification for prescribing more drugs.

Which brings us to the centerpiece of this spectacularly flawed article. The researchers boast about analyzing a "large, real-world US clinical dataset" of over 58,000 adults with opioid, alcohol, or cannabis dependence. Where did they get this data? Straight from "state-funded and state-run mental health services."

According to their brilliant analysis of this Medicaid mill ledger, a clear pattern emerged: Women had higher odds of being diagnosed with anxiety, depression, and trauma-related disorders. Men, on the other hand, had higher odds of being diagnosed with schizophrenia or other psychotic disorders.

Let me save the researchers their next million-dollar grant. There is no biological mystery here. You are not looking at organic sex differences in psychiatric comorbidities; you are looking at the gendered behavioral management of acute chemical intoxication, disguised as diagnostic science.

Let's break down the sheer absurdity of diagnosing "schizophrenia" in a man saturated in synthetic opioids or high-potency cannabis. Delta-9 THC at modern, concentrated levels induces acute paranoia, hallucinations, and psychotic breaks. Synthetic opioids induce profound central nervous system depression, cognitive detachment, and erratic neurological misfires.

When a drug-addicted male presents at a state-run clinic acting erratic, aggressive, or paranoid because his brain is literally swimming in neurotoxins, the clinic doesn't wait six months for him to sober up to see if he has actual, organic schizophrenia. They slap him with a psychosis billing code on day one. Why? Because a "psychosis" or "schizophrenia" code is the golden ticket to prescribe heavy, high-reimbursement antipsychotics like Seroquel or Haldol. It chemically lobotomizes the aggression, makes the patient compliant, and creates a highly profitable, permanent medical dependency.

Conversely, when a drug-addicted female enters the same clinic—emotionally shattered, crying, or suffering from the acute central nervous system blowback of alcohol or opioid withdrawal—she is immediately rubber-stamped with "anxiety," "major depressive disorder," or "trauma." Again, no one waits to see if her brain recalibrates after detox. The clinic simply uses the depression and anxiety codes to justify layering SSRIs, SNRIs, and benzodiazepines on top of her existing addiction.

This isn't a study of how male and female brains naturally develop mental illness. It is a ledger of how Medicaid mills code different intoxication behaviors to maximize pharmaceutical output. They took 58,000 people who were poisoned, looked at how the poison made the men act versus how it made the women act, and then handed out lifetime psychiatric labels to justify $14.2 trillion in MAT and polypharmacy cocktails. The only "integrated care" taking place in these facilities is the seamless integration of human suffering into a revenue stream.

Section 3: The Trauma Blindspot and the Chemical Lobotomy

If you want to see exactly where modern psychiatric research actively plays dumb to protect its funding, look at how Butelman and his colleagues handle trauma.

In their analysis of these 58,000 Medicaid patients, they note that females exhibited higher adjusted odds of "trauma- and stressor-related disorders"—running anywhere from 16% to 32% higher depending on whether the primary substance was opioids, alcohol, or cannabis. The authors then gaze thoughtfully at their data and write: "The dataset cannot tell us which of these explanations... accounts for the findings," waving their hands at some mysterious combination of biology, environment, and stigma.

Let me clear up the "mystery" for them using 50 years of established clinical metrics that the APA conveniently buried.

Between 60% and 80% of all addicts and alcoholics who walk through the doors of a treatment facility have been victims of sexual assault or severe, repeated trauma. They are fundamentally broken on a spiritual and emotional level. The entire reason they are pouring lethal amounts of fentanyl, alcohol, or cannabis into their bodies is to self-anesthetize. They are desperately trying to turn off the horrific reruns playing in their heads.

So, what does the modern MAT clinic do when a severely traumatized victim walks through the door? Do they treat the trauma therapeutically? Do they guide the patient through the rigorous, painful, but ultimately freeing process of abstinence-based cognitive and trauma therapies?

Absolutely not. That would require a sober brain capable of executive function and processing power.

Instead, Dr. Stupid and the billing department opt for a chemical lobotomy. They look at a patient who is using street drugs to numb their feelings, and their brilliant medical solution is to prescribe clinical drugs to numb their feelings. They slap a "trauma-related disorder" billing code on the chart and bury the patient under heavy psychiatric tranquilizers, SSRIs, and synthetic opioids like Methadone or Suboxone.

It is the clinical equivalent of watching a house burn down and trying to put out the fire with gasoline. No matter how many psychiatric drugs you dump on top of that brain, you are only keeping the trauma behind closed doors for a limited amount of time. The show is going to come back on. It will play on rerun after rerun after rerun. And when the trauma inevitably bleeds through the chemical haze, the clinic’s only response is to up the dosage. Ultimately, that methodology leads to a single, inevitable conclusion: respiratory failure and a casket.

But there is a darker, much more sinister reality hiding behind these "trauma" billing codes that the American Journal of Psychiatry absolutely refuses to touch. Since the year 2000—when the APA and CMS hijacked the addiction space and replaced abstinence with "harm reduction"—an estimated 10.5 million sexual assaults have gone entirely unreported by the treating psychiatrists, psychologists, medical doctors, and social workers.

You cannot have a 60% to 80% reported sexual abuse rate for 50 years and watch it magically dry up. If these clinicians were doing their jobs and reporting the trauma that drove the addiction, we would have 10.5 million police investigations. We would have billing records for 10.5 million hospital rape kits. But we don't. The data is suppressed, siloed, and ignored because reporting it requires actual trauma intervention rather than writing a prescription and sending the patient out the door.

Worse still, by chemically lobotomizing these individuals, the system actively sets them up for further abuse. As a clinician, I have investigated assaults occurring directly inside fake "sober living" facilities. Patients are heavily sedated by the MAT clinic's protocols, stripped of their cognitive defenses, and left profoundly vulnerable. When they inevitably relapse or are victimized again, the clinicians simply up the dose and ignore the assault. It is a traceable, complicit pattern: from the judge, to the clinician, to the sober living house, and straight to the grave.

Section 4: The “Integrated Care” Grift and the Section 13 Solution

Once Butelman et al. finish scratching their heads over trauma and psychosis, they deliver the ultimate punchline of the article. Citing Edmonds et al. (2024), they lament that "only 7% of US adults with co-occurring substance use and mental health disorder receive integrated treatment," using this as a rallying cry to expand their reach.

Let's translate "integrated treatment" from academic grift-speak into plain English.

Integrated treatment means expanding the pharmaceutical dispensary. It means ensuring that when you walk into an addiction clinic for a drug problem, the psychiatrist is waiting right down the hall to double-dip the billing codes and load you up with antipsychotics and mood stabilizers before you ever reach 24 hours of sobriety. It is a vertical monopoly on human suffering.

They want you to believe that the $14.2 trillion they’ve already spent on MAT and psychiatric cocktails wasn't enough. They want you to believe that the 600% increase in deaths—culminating in 4.6 million bodies and 700 dead Americans a day—is just a sign that we need more funding, more integration, and more drugs.

You cannot handle a drug problem with drugs. You end up with a Lindsey Clancy. You end up with a Matthew Perry. You end up with a nationwide string of corpses.

This article is an absolute gold standard of why the current system must be dismantled, and the blueprint to do it already exists. As the Congressional Relator of Record, I have already submitted the complete, comprehensive investigative dossier—The Assassination of Recovery—to the United States Congress, the Senate, and the Executive Branch.

Included in that dossier is the Section 13 Rescue Package: a fully drafted, legislative framework designed to rip the financial incentives away from the CMS billing mills, defund the polytoxic MAT pipelines, and restore the 91% success rate of abstinence-based, clinically sound recovery. We do not need more "integrated care" to pump narcotics into pregnant women and traumatized addicts. We need to shut the cartel down.

I strongly encourage every citizen, taxpayer, and family member who has watched a loved one be chemically lobotomized by this system to get The Assassination of Recovery into your legislator's hands. Demand the implementation of the Section 13 Rescue Package. It is time to stop subsidizing the world's biggest drug dealer.

Section 5: The Psychiatry Grift, the Marijuana Myth, and the $35.9 Trillion Reckoning

If we step back from the academic hand-wringing of this article, we have to ask the most fundamental question of all: Why are we treating chemical dependency—which is a medical disease concept, fourfold in nature—with psychiatrists in the first place?

The brutal reality is that modern psychiatrists operating in the MAT pipeline are not treating addiction. They are modern-day pill pushers. They hang a shingle with an "MD" after their name, and that shingle serves as a direct, frictionless pipeline: from the pharmacy, to the patient, to the Medicaid billing department, and straight into their pockets. Mental health is being abused for money, and intentional misdiagnosis is the name of the game. Who is going to fight it? After all, they are the "experts."

But the fraud goes much deeper than the doctor’s chair. Walk into any modern MAT facility running an Intensive Outpatient Program (IOP), and look at who is actually running the groups. It is often a "peer support specialist." This is someone who holds a meaningless 16-hour certificate, is usually taking MAT drugs or heavy psychiatric cocktails themselves, and is actively high while sitting in the facilitator's chair.

The clinic pays that peer support stoner $12 to $18 an hour. Meanwhile, the facility turns around and bills Medicare and Medicaid at a Master’s or PhD clinical level—anywhere from $245 to $565 an hour. That is a 200% to 400% fraudulent markup. Independent journalists like Nick Shirley recently discovered "learning centers" that were billing the government for phantom children, defrauding taxpayers of $20 billion. In the addiction space, $20 billion isn’t even a rounding error. It is a drop in the bucket compared to the $35.9 trillion financial extraction we have forensically documented in the dossier.

And then there is the article’s casual inclusion of "cannabis dependence," treating it like just another mild comorbidity. Let's talk about modern marijuana. Today's cannabis is genetically modified to be up to ten times stronger than what existed decades ago. In March, the largest study ever conducted on emergency room visits for marijuana overdose was published, and the results should terrify every parent and lawmaker in the country: 70% of those patients went on to develop early-onset Alzheimer's within five years. We are talking about 30- and 35-year-olds walking around with the brain function of a 70-year-old. We broke this down entirely in our piece Are You Stoned or Stupid, which you can find at help2LIR.

The academic authors of this article, and the psychiatric system they represent, do not know what they are doing because they shouldn't be doing it in the first place. This disaster will never stop until a power greater than these clinical grifters is exercised. The very people who created this problem over the last 26 years—the Congress, the Senate, and the Executive Branch—are the only ones who can bring it to a screaming halt.

If they do not act, predictive modeling shows that the current body count of 4.6 million is going to look like child's play within the next four years. We are losing 700 lives a day. We are burning $4.1 billion a day. The only things this system is producing are runaway inflation and death. If you have ever looked at the $40 trillion national debt clock and wondered where the money went, we found $35.9 trillion of it hiding in the medical billing silos.

All the money in the world will not bring back your wife, your husband, your son, or your daughter from this system's "care." If you have a family member who has been grossly harmed or killed by these protocols, you need to consult an attorney specializing in Constitutional violations and medical malpractice. We have provided enough verified data, billing codes, and historical metrics in our publications that any competent attorney can walk right into a courtroom and tear these clinics apart.

So, to the researchers at the American Journal of Psychiatry and The Mental Elf, thank you for providing the perfect case study of a system entirely disconnected from clinical reality.

We hope this introduction to your new drug dealer, Dr. Stupid, and the clinical assessment at your local MAT clinic has shown you the truth: if you walk through those doors, you are walking into a predictable failure. The only solution is true, abstinence-based recovery.

We strongly encourage you to get the comprehensive investigative dossier, The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud, into the hands of your legislators. Visit us at help2LIR to learn the truth, share the truth, and make a difference.

There is an old saying in recovery: When the pain of what you're doing outweighs the pain of change, you'll change.

Help us make a difference. Drop the book or our links to your Congressman or Senator. 

Read The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud.

Retail Purchase Links Here: Amazon | Barnes & Noble | Kobo | Google Play | Apple Books | Draft2Digital | IngramSpark

FREE: Audio Sample, The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud

Purchase the full 8 hour 55 min. audiobook:

⁠⁠⁠THE ASSASSINATION OF RECOVERY: The Whistleblower's Dossier on the $35.9Trillion Extraction and America's Deadliest Medical Fraud

THE 66-YEAR-OLD GHOST IN THE MACHINE: WHAT CYCHLORPHINE ACTUALLY IS

The media headlines are screaming about a "brand new, terrifying super-drug" hitting the streets that makes fentanyl look like baby aspirin. The talking heads call it an unprecedented chemical mystery.

It is neither new nor a mystery.

The drug is cychlorphine (chemically designated as N-propionitrile chlorphine). It is not the brainchild of a rogue street chemist or a dark-web prodigy. It is a 66-year-old pharmaceutical discard.

Back in the late 1950s and 1960s, commercial pharmaceutical laboratories in Belgium and across Europe were racing to discover potent painkillers that could tame the excruciating agony of terminal cancer and major orthopedic trauma. During that same era, Dr. Paul Janssen synthesized fentanyl. Fentanyl worked: it was roughly 100 times stronger than morphine, but it possessed a manageable safety margin. In a hospital surgical suite with an anesthesiologist monitoring an oxygen line, it could be controlled.

In that exact same wave of 1960s research, scientists mapped out the "orphine" chemical family, giving birth to compounds like brorphine, chlorphine, and cychlorphine. But while fentanyl went to the hospital pharmacy, cychlorphine was tossed straight into the biohazard bin. Why? Because its therapeutic window did not exist. In plain English: the dose required to relieve pain and the dose that permanently turned off the brain's breathing reflex were essentially identical. It was abandoned because it was not a medicine; it was a biological death sentence.

Now, six decades later, it has been pulled off library microfiche to feed an insatiable illicit supply chain.

THE POTENCY SCALE

Public health advisories from the White House Office of National Drug Control Policy (ONDCP) and the Center for Forensic Science Research and Education (CFSRE) estimate cychlorphine at roughly 10 times more potent than fentanyl. That translates to roughly 500 to 1,000 times the potency of standard medical morphine.

THE STREET NAME ILLUSION

The public imagines dealers standing on street corners peddling bags stamped "Cychlorphine." That is pure fantasy. You will never hear a street-level buyer ask for it, and the dealer selling it does not even know it is in the bag. Cychlorphine is an invisible, upstream phantom. It is blended into bulk powders to boost weak batches or pressed into counterfeit blue "M30" oxycodone, Xanax, or Percocet pills destined for suburban bedrooms, college dorms, and urban encampments.

THE RAPID-FIRE POISONING REALITY

A single grain of common table salt weighs around 60 micrograms. A lethal dose of cychlorphine is smaller than that single grain. When a human body encounters an opioid of this magnitude, there is no prolonged nod, no gradual drift into sleep, and no desperate gasp for breath. The compound binds to the brainstem's opioid receptors with terrifying speed, instantly paralyzing the respiratory center.

The tragic irony? While public health bureaucrats pat themselves on the back for distributing fentanyl test strips (FTS), cychlorphine is chemically invisible to standard fentanyl test strips and routine 10-panel hospital urine screens. The test strip comes up clean, the user believes the pill is safe, and within three minutes the coroner is called.

INDUSTRIAL SYNTHESIS, POSTAL VECTORS, AND THE PILL-PRESS ASSEMBLY LINE

The second great illusion sold to the public is that illicit drugs are cooked up by local crews in neighborhood basements. Nobody is synthesizing cychlorphine in an American garage. The modern illicit market operates like an agile transnational corporation, relying on global chemical arbitrage, micro-parcel logistics, and domestic mechanical assembly.

THE OVERSEAS CHEMICAL FOUNDRY

The actual chemical synthesis takes place thousands of miles away, predominantly inside commercial-grade chemical facilities and rogue laboratory complexes operating across China. When international law enforcement tightened restrictions on traditional fentanyl precursors like 4-ANPP, and especially after China enacted class-wide controls on nitazene-class opioids in July 2025, foreign chemical syndicates simply pivoted to past scientific literature. They pulled non-scheduled 1960s orphine compounds like cychlorphine off the shelf. Because cychlorphine relies on generic, unmonitored industrial reagents rather than flagged fentanyl building blocks, foreign export operations can manufacture the finished active pharmaceutical ingredient legally or semi-legally under the guise of commercial research chemicals.

MICRO-PARCELS AND CARTEL SUPPLY PIPELINES

Transporting legacy plant-based drugs like cannabis, cocaine, or crude black-tar heroin historically required subterranean tunnels, cargo shipping containers, and heavily compromised border crossings. Moving cychlorphine requires nothing more than an envelope. Because cychlorphine is ten times more potent than fentanyl, a single kilogram of pure powder contains millions of fatal doses. Overseas suppliers package pure, off-white cychlorphine powder into modest express airmail shipments, disguised as industrial toner, cosmetic mica, or raw plastic pigments. These packages slip straight through standard international mail sorting facilities directly into American cities. At the same time, major transnational syndicates, including the Sinaloa and Jalisco New Generation networks, have incorporated these pure orphine consignments into their wholesale distribution hubs to reinforce depleted fentanyl stocks and maximize chemical hook across retail distribution lines.

THE DOMESTIC MECHANICAL MILL

Once the concentrated chemical reaches domestic soil, local networks perform no organic chemistry whatsoever. Their role is purely mechanical: cutting, blending, and pressing. Operating out of suburban rental homes, garages, and nondescript industrial park bays across the country, processing crews use commercial ribbon blenders to stretch microscopic amounts of cychlorphine across pounds of inert tableting binders, such as microcrystalline cellulose, lactose, and cornstarch. They frequently toss in cheap illicit stimulants like methamphetamine or black-market tranquilizers like bromazolam and xylazine to tweak the perceived profile of the high. From there, industrial rotary pill presses outfitted with counterfeit pharmaceutical dies stamp out roughly ten thousand counterfeit prescription pills an hour.

THE CHOCOLATE CHIP COOKIE HAZARD

Clandestine tableting operations possess none of the micro-blending standards or strict quality controls demanded of legitimate pharmaceutical plants. When a baker mixes chocolate chips into cookie dough by hand, the chips never distribute with mathematical equality; one cookie ends up with two chips, while another ends up with twenty. In a production run of fifty thousand pressed counterfeit tablets, uneven blending leaves microscopic clumps of pure cychlorphine scattered throughout the batch, creating lethal hotspots. One counterfeit pill may deliver a mild, muted effect, while the next pill off the tray contains five hundred micrograms—a concentrated payload sufficient to shut down the respiratory drive of multiple adults before the tablet has even dissolved in the stomach.

CLINICAL TOXICOLOGY, COMPARATIVE HISTORY, AND FATAL POLYSUBSTANCE DYNAMICS

The divergence between fentanyl and cychlorphine comes down to a fundamental medical dividing line: the width of the therapeutic safety window.

THE FENTANYL TRAJECTORY VERSUS CYCHLORPHINE'S HISTORICAL ABANDONMENT

Dr. Paul Janssen synthesized fentanyl in Belgium in 1959–1960 to solve an operating-room crisis: morphine was too slow to kick in, hung around in the body too long, and caused dangerous drops in blood pressure. Fentanyl was roughly 100 times stronger than morphine, but it acted in minutes, left the cardiovascular system stable, and cleared quickly. It offered a predictable therapeutic window—the safety margin between relieving severe pain and stopping the lungs. In controlled surgical theaters with mechanical ventilators, anesthesiologists could dial it in safely, eventually leading to its approval for terminal cancer pain in the 1990s.

During that same pharmaceutical era, researchers hunting for ultra-potent analgesics synthesized the orphine family, including cychlorphine. It was permanently shelved because its therapeutic index was virtually zero. The dose required to control intractable cancer pain was indistinguishable from the dose that paralyzed the brain's breathing reflex. In lay terms: fentanyl was a sharp scalpel that could be guided safely by a trained doctor; cychlorphine was an uncontrolled sledgehammer that suffocated test subjects almost instantaneously.

LETHALITY IN PRACTICAL TERMS

If standard medical morphine is a drop of water, fentanyl is a shot glass, and cychlorphine is a firehose. Cychlorphine is estimated at 500 to 1,000 times stronger than morphine and roughly 10 times stronger than fentanyl. Medical examiners have documented fatal poisonings with blood concentrations as minuscule as 0.5 nanograms per milliliter, which represents half of one-billionth of a gram. A lethal dose is invisible to the human eye, measuring smaller than a single grain of baker's salt.

RECEPTOR MECHANICS AND THE LOCKED CHEST

Once introduced into the bloodstream, cychlorphine floods the brainstem’s -opioid receptors with extreme binding grip and affinity. It immediately shuts off the body's internal carbon dioxide alarm system. A person does not feel air hunger or choke; they simply fall into a coma within seconds as their respiratory rate drops from twelve to sixteen breaths per minute straight to zero. Like other ultra-potent synthetics, intense receptor binding can trigger acute chest-wall rigidity, commonly referred to as wooden chest syndrome. In this state, the intercostal muscles lock up entirely, turning the ribcage rigid and making unassisted rescue breathing mechanically impossible without immediate pharmacological reversal and intubation.

INTERACTIONS WITH MEDICATION-ASSISTED TREATMENT REGIMENS

When it comes to buprenorphine, the primary ingredient in Suboxone, the drug operates as a partial agonist with a very tight receptor grip designed to block other street opioids. However, when an individual stable on Suboxone unknowingly ingests cychlorphine, cychlorphine's sheer mass-action potency can punch right through the buprenorphine blockade. Because the individual assumes they are pharmacologically protected, an unexpected, catastrophic overdose can occur without warning.

With methadone, the risk profile changes entirely. Methadone is a long-acting, full opioid agonist that builds up in bodily tissue over time, offering no ceiling effect on respiratory depression. Taking cychlorphine on top of daily methadone creates compounded full-agonist toxicity, causing the brain's respiratory drive to collapse under the combined weight of two long-acting, ultra-potent depressants operating at the same time.

As for pure narcotic antagonists like naloxone, the antidote does not induce death or cause a toxic chemical reaction. It remains the frontline rescue agent. However, because cychlorphine clings to brain receptors with profound tenacity, standard 4-milligram nasal sprays often get bounced off the receptor site. First responders routinely report that victims require three, four, or more successive doses of naloxone alongside bag-valve-mask ventilation to displace the compound and restore spontaneous respiration.

THE FATAL MULTIPLIER AND POLYSUBSTANCE SATURATION

The single most lethal combination encountered with cychlorphine is co-ingestion with central nervous system depressants, specifically benzodiazepines like alprazolam and illicit bromazolam, or veterinary tranquilizers like xylazine. Because naloxone only reverses the opioid receptor component, it cannot reverse the cellular shutdown caused by heavy sedatives, locking the body into irreversible hypoxia before emergency personnel can arrive on scene. Forensic post-mortem casework from regional death clusters confirms that decedents are overwhelmingly polysubstance saturated. In the vast majority of documented cychlorphine deaths, toxicological screens reveal a lethal mixture of cychlorphine combined with illicit fentanyl, methamphetamine taken to counteract the extreme sedative drop, cocaine, and designer sedatives, with pure cychlorphine appearing as a solitary agent in only a minor fraction of autopsies.

THE PREDICTABLE OVERDOSE: HOW DESTROYING RECOVERY MANUFACTURED A $35.9 TRILLION BODY COUNT

The arrival of cychlorphine is not an unpredictable act of chemical fate. It is the mathematically engineered end-state of a 26-year institutional collapse: the systematic eradication of authentic, abstinence-based recovery in America. When a regulatory apparatus spends two and a half decades dismantling programs that produce sober, self-sufficient human beings, it does not solve an addiction crisis. It constructs an industrial pipeline that delivers living individuals directly to the county morgue.

THE ERASURE OF ABSTINENCE AND THE $35.9 TRILLION MONOPOLY

For the better part of the twentieth century, the benchmark of addiction treatment was rooted in an uncompromising objective: complete, unadulterated sobriety. Anchored in rigorous residential immersion, twelve-step integration, radical self-honesty, and emotional maturity, long-term abstinence-based programs historically produced sustained recovery rates between 51% and 91% for individuals who fully worked the process. Millions of people—from celebrated rock icons like Joe Walsh to everyday tradespeople, attorneys, and parents—reclaimed their lives, re-entered the economy, raised families, and stayed clean for twenty, thirty, or forty years without asking society to pay for recurring emergency interventions or state-funded maintenance doses.

That proven paradigm was dismantled to clear the path for a lucrative pharmaceutical extraction model. Over the last quarter-century, an entrenched alliance of regulatory architects, academic grant recipients, and pharmaceutical corporations systematically rebranded abstinence as an outdated, punitive relic. Under the deceptive banner of "harm reduction" and lifelong Medication-Assisted Treatment, real recovery was redefined as perpetual chemical management. Centers for Medicare & Medicaid Services billing codes were expanded, commercial insurance mandates fell into lockstep, and public health policy declared that chemical dependence could only be managed by trading street narcotics for state-sanctioned synthetic opioids. The economic devastation of this shift is monumental. Across the broader economy, the cumulative damages and institutional extractions of this engineered crisis represent a staggering $35.9 trillion drain—a colossal transfer of public and private wealth that has enriched clinical conglomerates while leaving families financially gutted and utterly devastated.

WALKING IN PERPETUAL RELAPSE: THE POLYPHARMACY TRAP

The fundamental deception of the modern symptom management paradigm is the claim that an individual stabilized on daily synthetic narcotics is safe from catastrophic street drugs. In truth, an individual maintained on an MAT protocol is walking through life in a chemically compromised, partially wasted baseline state. Because the underlying spiritual, emotional, and behavioral roots of addiction are left untouched by a daily pharmaceutical dose, the individual is effectively living in permanent pre-relapse. When the inevitable personal crisis hits—a broken relationship, the loss of employment, a death in the family, or simply a prolonged period of deep emotional despair—the biological instinct to numb reality takes over.

Compounding this psychological vulnerability is a routine, clinical reality: the contemporary patient is rarely taking just a single maintenance drug. Instead, they are chemically saturated with complex psychiatric cocktails. It is routine to find individuals prescribed combinations of high-dose buprenorphine or methadone, massive daily dosages of gabapentinoids, sleep-inducing sedatives, and mood-altering psychiatric agents. In clinical practice, these combinations routinely drive a patient's total central nervous system depressant load 400% or more beyond standard Physicians' Desk Reference and DEA safety baselines. These individuals are not living in stable recovery; they are balancing on a razor-thin toxic bell curve, where their respiratory system is already functioning near critical capacity.

FROM HARM REDUCTION TO HORIZONTAL CORPSE: THE MICROSCOPIC TRIGGER

When a person whose central nervous system is already suppressed by daily methadone or high-dose buprenorphine crosses paths with cychlorphine, the biological margin for survival disappears entirely. Consider the practical reality of what it takes to transition from supposed "harm-reduction maintenance" to a horizontal corpse on an autopsy table. A single grain of common baker's salt weighs roughly 60 micrograms. If you were to take that single grain of salt and crush it into a dozen microscopic dust particles, just one of those airborne flecks represents an active lethal dose of cychlorphine for a chemically naive person.

For someone already sitting on the toxic bell curve—whose blood is carrying an around-the-clock load of prescribed opioids, anti-anxiety tranquilizers, and antidepressants—that microscopic threshold shrinks even further. It does not require a full pressed tablet or a noticeable line of powder to overwhelm the system. In this pre-saturated biological state, the addition of a sub-microscopic trace of cychlorphine, an amount literally invisible to the human eye, exerts an instantaneous, overwhelming displacement on brainstem receptors. The individual does not even have the physiological reserve to execute a struggle. The respiratory drive terminates immediately, the ribcage seizes into rigidity, and cardiac arrest follows within minutes. The system promised them safety; the pharmacology delivers instant asphyxiation.

INSTITUTIONAL COMPLICITY: DRUG COURTS AND THE TWO-YEAR DEATH PROJECTION

This lethal mechanism is not merely occurring on forgotten street corners; it is actively enforced by institutional authority. Across the nation, specialized drug courts, probationary diversion programs, and municipal criminal justice mechanisms have largely ceased utilizing non-punitive referrals to long-term, abstinence-based therapeutic communities. Instead, compliance is frequently tied directly to enrolling in Medicaid-reimbursed MAT clinics. Traditional, twelve-step, faith-based, or long-term abstinence recovery centers have been starved of resources, de-credentialed, or driven out of operation by state regulatory bodies that refuse to certify facilities that do not distribute pharmaceutical narcotics. Society has intentionally eliminated the only off-ramp that leads to complete sobriety.

Under these current protocols, the trajectory for the next two years is mathematically grim. With cychlorphine establishing an irreversible foothold in the illicit supply chain, and with traditional abstinence-based recovery remaining virtually inaccessible to the average citizen caught in the court system, a standard probability index indicates that fatal drug overdoses will accelerate an additional 25% to 40% across impacted metropolitan corridors over the next 24 months. When policy artificially preserves a population in a state of perpetual chemical dependence, it guarantees an unrelenting market demand. And when that consumer demand collides with a 66-year-old laboratory discard that is ten times more lethal than fentanyl, the outcome is not an unfortunate statistical accident. It is a predictable, state-subsidized fatality.

THE COGNITIVE GUILLOTINE: COMMERCIAL THC, ALCOHOL, AND THE ENGINEERED ASSEMBLY LINE TO THE CEMETERY

If an adversary wanted to design a domestic population incapable of basic survival, they could not construct a more efficient pipeline than the modern American addiction paradigm. To understand how a microscopic speck of a 66-year-old discarded chemical like cychlorphine guarantees instant death, you have to look at the engineered state of the human target walking into the crosshairs.

THE "NEW STUPID": HIGH-POTENCY CANNABIS AS THE COGNITIVE NEUTRALIZER

The romanticized myth of marijuana as a harmless, natural herb plucked from a 1969 Woodstock pasture is a marketing fabrication. The ditch-weed of the 1960s and 1970s carried a tetrahydrocannabinol (THC) concentration between 1% and 3%. Today’s state-licensed commercial dispensary menu features genetically engineered hybrid flower testing at 25% to 35% THC, and solvent-extracted concentrates, distillates, and vapes reaching 90% purity. This is not the gentle mood-lifter of your parents' generation; it is an industrial neurotoxin that chemically strips away executive functioning, prefrontal cortex inhibition, and situational survival instincts.

As established in Are You Stoned or Stupid?, the practical outcome of chronic saturation with supercharged THC is the systematic dismantling of critical reasoning. It does not simply relax the user; it induces an intellectual paralysis—the "new stupid"—leaving the user incapable of assessing obvious physical hazards or calculating risk. Yet, under the political stampede to commercialize and tax it in all 50 states, this profound cognitive depressant is handed out with a societal clean bill of health.

THE PERMISSIVE MAT BLINDSPOT: FREE PASSES ON WEED AND ALCOHOL

Step inside the average Medicaid-funded Medication-Assisted Treatment clinic and observe the administrative theater. The patient is handed a daily dose of synthetic narcotics—methadone or buprenorphine—often paired with towering psychiatric cocktails of gabapentinoids, sleep aids, and mood stabilizers that push central nervous system depressant levels hundreds of percent past Physicians' Desk Reference safety baselines. One only needs to examine the devastating real-world precedent of the Lindsay Clancy tragedy to see the catastrophic neurological break that occurs when a patient is subjected to over a dozen distinct mind-altering medications in a compressed four-month span.

Yet, despite this hair-trigger chemical baseline, the clinic’s testing protocols look the other way. Because commercial cannabis is state-sanctioned, the clinic does not flag or discipline for high-potency THC. Because alcohol is legal, a patient maintained on daily opioids is given a free pass to binge drink over the weekend or wash down their evening dose with a six-pack. The clinical bureaucracy declares that because the patient's primary diagnosis was an opioid dependency, flooding their bloodstream with alcohol and neuro-paralyzing THC is perfectly acceptable "harm reduction." It is an administrative license to walk through the world in a state of permanent, multi-layered chemical stupor.

THE RECEPTOR CON: SAME TARGET, SAME CRASH, DIFFERENT DOOR

The clinical excuse that an opioid patient can safely consume alcohol because their "problem was narcotics" is one of the most intellectually bankrupt lies in modern addiction medicine. To the human central nervous system, this distinction does not exist. While alcohol enters through the stomach and opioids enter through a pill, a line, or a vein, both substances converge on the exact same neurological real estate: the mesolimbic dopamine reward pathway and the vital breathing centers of the brainstem.

Opioids bind directly to the opioid receptors, which sit heavily clustered across the ventral tegmental area and the medullary respiratory center in the brainstem. Alcohol works as a dirty pharmacological bomb: it floods gamma-aminobutyric acid (GABA) receptors to shut down neurological firing, while concurrently stimulating the release of endogenous beta-endorphins that lock onto those very same opioid receptors. At the cellular level, alcohol triggers the identical downstream opioid cascades, paralyzing the prefrontal cortex and turning down the brainstem's carbon dioxide drive. When a clinic tells an opioid patient that drinking is fine because "alcohol isn't an opiate," they are ignoring fundamental neurobiology: it is the exact same receptor system, the exact same neurological sedation, and the exact same respiratory brake pedal—just delivered through a different ingestion tract.

THE POLYSUBSTANCE DEAD END: ZERO DEFENSE AGAINST CYCHLORPHINE

Take an individual in this exact state: brainstem already suppressed by high-dose daily methadone, neurological executive function knocked offline by 30% dispensary weed, balance and reflex control dull from weekend alcohol intake, and psychiatric meds running at maximum volume. They have had a catastrophic week—lost their job, suffered a devastating breakup, or buried a family pet. Living in an engineered state of permanent pre-relapse with zero emotional coping mechanisms and zero abstinence-based tools, the biological drive to escape emotional pain is absolute.

They reach for what they believe is a street Xanax or a counterfeit pain pill to numb the ache. Because their cognitive radar was dismantled by commercial THC and alcohol, they lack the basic survival skepticism to question the tablet. And because their bloodstream is already drowning in an MAT-prescribed depressant cocktail sharing the exact same sedated neurological pathways, their biological margin for survival is non-existent. When the pill delivers an invisible micro-speck of cychlorphine—ten times stronger than fentanyl, 1,000 times stronger than morphine—the pharmacological reaction is instantaneous. There is no biological reserve left to fight. The respiratory center collapses on impact, the chest locks tight, and the individual transitions from state-sponsored "symptom management" to a horizontal corpse on the coroner’s slab.

THE DEMOGRAPHIC SLAUGHTER: ACCELERATING THE DAILY BODY COUNT

Look at the intake manifests of local county morgues: these are not 55, 65, or 75-year-old retirees succumbing to cychlorphine hotspots. The decedents are predominantly twenty- and thirty-somethings—young people systematically fed into a predatory medical and penal apparatus that dismantled long-term, 12-step abstinence recovery centers and replaced them with lifetime chemical subscriptions.

Currently, the daily American casualty rate from drug poisonings sits at a relentless baseline of roughly 700 dead citizens every single day. When you apply an actuarial probability index that adds the projected 25% to 45% fatality escalation directly driven by orphine-class compounds like cychlorphine infiltrating an already MAT-saturated, cannabis-dulled youth population, the arithmetic is horrifying. That baseline surges from 700 bodies a day to well over 900 to 1,000 corpses every single 24 hours. That is an additional 70,000 to 100,000 young lives wiped out annually, pushing the cumulative human toll toward catastrophic historical heights.

This is the real dividend of a policy managed by 31,000 judges, 82,000 prosecutors, complicit correctional facilities, and mega-pharmaceutical corporations backed by a blind, fee-collecting legislative apparatus. By trading authentic, lifelong sobriety for a multi-trillion-dollar chemical management racket, society did not protect our youth; it merely engineered a faster, state-subsidized route to the cemetery.

EXECUTIVE SUMMARY AND CALL TO ACTION: LIVE THE SOLUTION, NOT THE PROBLEM

Nobody ever woke up at five years old and declared, "I can't live without a fifth of Jack Daniels today." I have never seen a seven-year-old determine that their life in the second grade would be vastly improved by a cocaine habit, nor do nine-year-olds inherently seek out opioid dependency. However, once the genetic predisposition is triggered and those initial choices are made, the option to simply say no is removed from the equation until the individual is given new data and a new way to live. The choice itself is brutally binary: if you have a problem, do not feed it. If you do not have a problem, do not start one.

There is no opioid crisis in America; there is a treatment crisis. When the government codified Supplemental Security Income (SSI) regulations in 1996, and when the American Medical Association evaluated addiction, the conclusion was unambiguous: the cure for alcoholism and drug addiction is complete abstinence. Yes, individuals will be physically and emotionally uncomfortable in withdrawal. Providing them with proper, medically supervised facilities solves that hurdle. True recovery demands that people choose whether they want to continue engaging in their destructive behaviors; if they do, they must suffer the natural consequences of those actions. Instead, society invented the myth of "harm reduction" and "symptom management"—a system so grotesquely broken that 87% of chemically saturated users are routinely let out of jail simply because they are so toxic the local municipalities refuse to risk a wrongful death lawsuit on their watch.

Albert Einstein famously noted that the same mind that caused a problem cannot fix the problem. By that exact logic, taking away all the known, long-term recovery options that actually worked—programs that historically produced a 91% success rate after five years—and replacing them with a strategy of giving more drugs to drug addicts and letting alcoholics drink is not a medical breakthrough. It is institutionalized insanity. When you strip away abstinence and substitute it with lifetime pharmacological subscriptions, all you have to do is look at the national death clock and the overflowing cemeteries to realize it is not a solution. The flat line of state-sponsored symptom management will only grow horizontally, while the vertical line for true, abstinence-based recovery remains completely flat until the system is forced into a hard reset.

Every single element of this catastrophe is resolvable. The issue is not a lack of scientific understanding; it is a lack of legislative willpower and an absolute addiction to healthcare inflation. We cover the precise mechanics of this collapse—and the exact blueprint for its resolution—in The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud. The entire evidentiary dossier is already in the government's hands. It was requested by the House Oversight Committee; it sits in the possession of the House Judiciary Committee as the relator of record, and it was delivered to the Senate and executive branches as far back as February. Yet, here we are, watching the legislative apparatus protect a $35.9 trillion billing machine and add to the national debt while the bodies pile up. They legislated this problem, whether through ignorance or deliberate indifference.

We have a comprehensive initiative designed to return to the successful, drug- and alcohol-free model where individuals are taught how to become functional members of society again—restoring their lives to be happy, joyous, and free. We invite you to explore this framework and join the fight by visiting us at Help2LIR. If you know a legislator, a policymaker, or anyone standing in the way of real recovery, turn them onto us. Send them our way and make them read The Assassination of Recovery. It is time to stop feeding the bureaucracy of death.

Live in the solution, not the problem.

Read The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud.

Retail Purchase Links Here: Amazon | Barnes & Noble | Kobo | Google Play | Apple Books | Draft2Digital | IngramSpark

FREE: Audio Sample, The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud

Purchase the full 8 hour 55 min. audiobook:

⁠⁠⁠THE ASSASSINATION OF RECOVERY: The Whistleblower's Dossier on the $35.9Trillion Extraction and America's Deadliest Medical Fraud

THE "SILVER BULLET" AND THE HORSE THIEF, WHY SYMPTOM MANAGEMENT DOESN'T WORK

 THE "SILVER BULLET" AND THE HORSE THIEF, WHY SYMPTOM MANAGEMENT DOESN'T WORK

"You can get better from a seemingly hopeless state of mind and body, but you cannot change genetics and biology."

For forty-five years of frontline clinical experience, I have watched the self-proclaimed "experts" chase an illusion. They call it a "Silver Bullet". They sell families a comforting, lethal falsehood: that if you simply feed a government-sanctioned chemical substitute to an addict, the problem magically dissolves.

They are dead wrong.

The Horse Thief Analogy

To understand why modern "harm reduction" is a catastrophic failure, consider a simple analogy. If you have a horse thief and you take away his horses, what do you actually have? You still have a thief. He still thinks, feels, and acts like a thief—he is simply going to walk into town and steal purses, wallets, or laptops instead.

This is the fatal flaw of symptom management. By focusing exclusively on the drug—the horse—the administrative state completely ignores the Four-Fold Disease: Physical, Emotional, Spiritual, and Psychological. They busy themselves "managing symptoms" while the core disease continues to rot the individual from the inside out.

The Failure of the Substitution Model

History exposes this recurring delusion. In the 1880s, medical pioneers attempted to cure Dr. William Halsted’s cocaine addiction by switching him to morphine, creating a lifelong dependent. Sigmund Freud infamously promoted cocaine as a miracle cure for opioid addiction, only to watch his colleague, Ernst von Fleischl-Marxow, perish under dual dependencies.

Today’s Medication-Assisted Treatment (MAT) infrastructure is built entirely on this exact, historically bankrupt substitution error. During the 50-year Golden Age of Recovery (1950s–1990s), the United States operated on an abstinence-based, disease-concept model that yielded long-term success rates between 51% and 91%. In the year 2000, the legislative branch assassinated that abstinence standard, replacing a true clinical cure with a permanent, state-funded subscription to chemical dependency.

Rather than stabilizing patients, modern MAT clinics routinely push dosages to 125mg to 225mg of methadone—soaring 400% past safe limits—while layering these synthetic narcotics with toxic psychiatric cocktails that explicitly violate FDA Black Box warnings. When an individual is chemically lobotomized by state mandate, they cannot authentically participate in 12-step recovery or achieve true freedom.

The Math of the Massacre

The results of this multi-decade experiment are written in a staggering body count and a massive financial hemorrhage:

The Funding Explosion: Federal funding for this "harm reduction" and symptom-management model has exploded by 1,500%, ballooning from $99 billion to $1.5 trillion annually.

The Clinical Success Rate: A flat 0.00% for long-term, drug-free abstinence, because the system legally defines the cessation of maintenance drugs as a "relapse".

The Human Toll: A 600% spike in national mortality, resulting in 4.6 million predictable casualties, including 3.5 million adult polysubstance deaths and 1.1 million infant fatalities born into state-mandated Neonatal Abstinence Syndrome (NAS).

The Financial Drain: Medicaid is drained of $320 billion annually to fund maintenance drugs, while the total annual cost to taxpayers for societal wreckage—courts, jails, and public defenders—reaches $1.5 trillion, eclipsing the entire U.S. defense budget.

The Lethal Result

When you fail to treat the heart of the thief, relapse is not merely a possibility—it is an absolute inevitability. In today's landscape of fentanyl and massive synthetic dosing, a slip-up does not mean a trip back to a meeting; it means a trip to the morgue.

Real recovery is never found on a chemical leash. It requires a total life overhaul: the 12 steps, a sponsor, rigorous personal honesty, and the hard, unvarnished work that makes life genuinely fun again.

Giving more drugs to a drug addict is like taking the horse away from the thief and expecting the thief to magically change.

Chemical Dependency is a biological disease that, in the last 85 years, common sense and SSI have only seen one way to “cure it”: complete abstinence from all drugs and alcohol. But leave it to greed, medical facilities, doctors, MAT, judges, or elite scholars to want to find a way to profit by feeding the sick “new cure”, more chemicals to enslave the addicted. Marijuana, Hallucinogens, Ketamine, psychiatric cocktails, all to “symptom manage,” reduce harm, and make a lifelong profit. If there was a Silver Bullet that didn’t produce the catastrophic cost and lives lost, it’s the simplest answer that was already discovered: none! Don’t load the person, and they won’t show any symptoms or damage from usage. Not profitable buy easier than trying one fatal “cure after the next”.

Only through treating the disease in a fourfold approach do you get the cessation of craving and the restoration of a productive life, neither a thief nor an addict anymore, but it works if you work “all of it” minus the mind- and mood-altering chemicals that ARE THE PROBLEM.

STOP ENABLING THE DISEASE. START DEMANDING THE THREAD OF TRUTH.

Get the book: The Assassination of Recovery: The Whistleblower’s Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud.

The moral of the story is that there is no shortcut to Addiction recovery, especially when you treat only one symptom instead of the whole disease.

Retail Purchase Links:

The Assassination of Recovery and the Help2LIR initiative bring this 26-year extraction into the light. Read the evidence. Share the truth. Be the voice that forces the change.

Retail Purchase Links Here: Amazon | Barnes & Noble | Kobo | Google Play | Apple Books | Draft2Digital | IngramSpark

FREE: Audio Sample, The Assassination of Recovery: The Whistleblower's Dossier on the $35.9 Trillion Extraction and America's Deadliest Medical Fraud